Incidence and predictors of left ventricular function change following ST-segment elevation myocardial infarction

Chuanfen Liu1,2,3, Meng Guo1,2,3, Yuxia Cui1,2,3

  • 1Department of Cardiology, Peking University People's Hospital, Beijing, China.

Insights

Left ventricular ejection fraction (LVEF) often decreases after ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). However, LVEF recovery is predictable by baseline patient characteristics.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Research

Background:

  • ST-segment elevation myocardial infarction (STEMI) is a critical condition requiring immediate intervention.
  • Primary percutaneous coronary intervention (PCI) is the standard treatment for STEMI.
  • Assessing left ventricular function post-STEMI is crucial for patient outcomes.

Purpose of the Study:

  • To determine the incidence of changes in left ventricular function after primary PCI in STEMI patients.
  • To identify predictors of left ventricular ejection fraction (LVEF) improvement or decline.
  • To understand long-term left ventricular function dynamics following STEMI treatment.

Main Methods:

  • A cohort of 312 STEMI patients undergoing primary PCI was enrolled.
  • Long-term follow-up data was collected for 186 patients.
  • Multiple logistic regression analysis identified independent predictors of LVEF change.

Main Results:

  • Over a median follow-up of 1,021 days, 54.3% of patients experienced a decrease in LVEF, while 45.7% showed improvement.
  • Independent predictors for LVEF improvement included lower peak troponin I, non-anterior STEMI location, lower baseline LVEF, and no prior myocardial infarction history.
  • Baseline characteristics were found to be associated with LVEF recovery post-primary PCI.

Conclusions:

  • A significant proportion of STEMI patients undergoing primary PCI experience a decline in LVEF over the long term.
  • Left ventricular ejection fraction recovery after STEMI is influenced by initial presentation and patient history.
  • Predicting LVEF changes based on baseline characteristics can aid in risk stratification and management.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
29
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
15
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
38
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
14
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
212
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
14